Integrated Cancer Services in Thailand: A Prototype for Excellence
NCT07600294 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 358
Last updated 2026-05-20
Summary
Cancer is a significant health crisis globally and specifically within Thailand, where it affects more than 122,000 individuals every year and leads to approximately 86,000 deaths. Beyond the physical and emotional toll on patients, the disease creates immense social and economic challenges.
In Thailand, cancer treatment costs exceed 26 billion baht (about $800 million USD) annually. Families often face out-of-pocket costs for cancer care that exceed 30% to 40% of their total household income. Furthermore, the aging of Thai society and lifestyle changes-such as "Westernized" diets and sedentary behavior-are expected to drive these numbers even higher. This situation has created an urgent need for new healthcare models that reduce the burden on major hospitals and make care more accessible to the public. The Project Goal: A new model of care to address these challenges: Researchers developed a prototype Center of Excellence in Integrated Cancer Services. The goal was to test whether a specialized cancer unit could be successfully integrated into a local community clinic rather than functioning as a large, separate hospital.
The study used Donabedian's model to evaluate quality, focusing on three specific areas: Structure: The physical setting, equipment, and staff. Process: How the services are actually delivered and Outcomes: The results of the care and the satisfaction of those involved. Phase of Development and Implementation The project was a three-year initiative funded by the National Science, Research, and Innovation Fund of Thailand. Phase 1: Focused on the conceptual design of the center. Phase 2: Involved detailed planning and the development of digital information systems. This is at Phase 3: Focused on the actual implementation and testing of the prototype center in Bangkok
Conditions
Interventions
- OTHER
-
Health Service Delivery Model
The intervention in this study is the development and implementation of a prototype Centre of Excellence (COE) in Integrated Cancer Services in Bangkok, Thailand. This model is fundamentally distinguished by its integration into a local community setting-specifically established within the Warm Community Nurse Clinic-rather than functioning as a standalone, large-scale hospital. By leveraging the community's existing familiarity with the clinic, the intervention aims to improve accessibility and trust while reducing the financial and logistical burdens typically associated with seeking cancer care at major medical centers.
Sponsors & Collaborators
-
Chulabhorn Royal Academy
collaborator OTHER -
Chulabhorn Cancer Center
lead OTHER
Principal Investigators
-
Vilaivan Thongcharoen, PhD · PAFN, CRA
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-03-02
- Primary Completion
- 2024-07-13
- Completion
- 2024-07-13
Countries
- Thailand
Study Locations
More Related Trials
-
Predictive Tools in Head and Neck Cancer Patients Undergoing Radiotherapy
NCT06806683 ·Status: ACTIVE_NOT_RECRUITING
-
Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity
NCT01163552 ·Status: COMPLETED ·Phase: PHASE2
-
Hypofractionated Radiotherapy for Thymic Epithelial Tumors
NCT06692062 ·Status: RECRUITING ·Phase: NA
-
Adjuvant Chemotherapy for Locally Advanced Cervical Cancer
NCT02036164 ·Status: UNKNOWN ·Phase: PHASE3
-
Boron Neutron Capture Therapy (BNCT) for Locally Recurrent Head and Neck Cancer
NCT01173172 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Individualization of Nutritive Sensory Support Of Radiation Therapy
NCT05046028 ·Status: COMPLETED ·Phase: PHASE4
-
Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda
NCT07276360 ·Status: RECRUITING ·Phase: PHASE2
-
Lesion-Allocated Therapy for Multiple Metastases and Tumor-Zoned Treatment for Bulky Tumors: A Phase II Study of Iodine-125 Seed Implantation Combined With Cryoablation in High-Burden Metastatic Disease
NCT07437625 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Nutrition and Inflammation in Patients with Head and Neck Cancer
NCT03343236 ·Status: ACTIVE_NOT_RECRUITING
-
InGReS: Intra-treatment Image Guided Adaptive Radiotherapy Dose-escalation Study
NCT05393297 ·Status: UNKNOWN ·Phase: NA
-
BNCT and IG-IMRT for Recurrent Head and Neck Cancer
NCT02004795 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Late Sequelae of Childhood and Adolescent Nasopharyngeal Carcinoma Survivors After Radiotherapy
NCT03398980 ·Status: COMPLETED
-
Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer
NCT05800574 ·Status: RECRUITING ·Phase: PHASE2
-
Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck
NCT00002932 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer
NCT02206334 ·Status: COMPLETED ·Phase: PHASE1
-
Quality of Life Before and After Radiotherapy in Patients With Head and Neck Cancer
NCT06807697 ·Status: COMPLETED
-
A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck Cancer
NCT01111942 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life
NCT06136962 ·Status: NOT_YET_RECRUITING
-
Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer
NCT02184533 ·Status: COMPLETED ·Phase: PHASE1
-
Immunostimulating Interstitial Laser Thermotherapy in Solid Cancers
NCT02690428 ·Status: TERMINATED ·Phase: NA
-
Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer
NCT00006360 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Cryoablation Combined With Radiation Therapy for the Palliation of Painful Bone Metastases
NCT01461252 ·Status: WITHDRAWN ·Phase: PHASE1
-
Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer
NCT00629226 ·Status: COMPLETED ·Phase: PHASE1
-
Health and Economic Outcomes of Two Different Follow up Strategies in Effectively Cured Advanced Head and Neck Cancer
NCT02262221 ·Status: SUSPENDED ·Phase: NA
-
Change in Symptom Clusters in HNC Patients
NCT03356093 ·Status: COMPLETED